Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantationJuan Luis Steegmann, J M Fernández-Rañada, Luis Casado et al.|Bone Marrow Transplantation|1999Cited by 32
A Phase I Study of Molibresib (GSK525762), a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of a Phase I/II Open Label Single Agent Study in Subjects with Non-Hodgkin's Lymphoma (NHL)Michael Dickinson, Anastasios Karadimitris, Raúl Córdoba et al.|Blood|2018Cited by 15